Effect of dietary approaches to stop hypertension diet plan on pregnancy outcome patients with gestational diabetes mellitus

Authors

  • Jie Yao Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022
  • Lin Cong Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022 http://orcid.org/0000-0002-4727-6472
  • Benli Zhu Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022
  • Ting Wang Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022

DOI:

https://doi.org/10.3329/bjp.v10i4.23813

Keywords:

DASH, Pregnancy outcomes, GDM, Randomized controlled clinical trial

Abstract

The purpose of this study is to test the effects of Dietary Approaches to Stop Hypertension (DASH) diet plan on pregnancy outcomes patients with gestational diabetes mellitus. This randomized controlled clinical trial was performed among 33 women diagnosed with gestational diabetes. These patients were randomly distributed to the control group (n = 16) or DASH diet group (n = 17) for 4 weeks. Whereas 47.1% of women in the DASH diet needed to have a cesarean section, this percentage of mean gestational age in control diet was 81.3% (p<0.01). Approximately 23.5% of women in the DASH diet and 75% of women in control diet needed to commence insulin therapy after intervention (p<0.01). In conclusion, the effect of DASH diet improved pregnancy outcomes patients with gestational diabetes.

Downloads

Download data is not yet available.
Abstract
4232
Download
1325 Read
874

Downloads

Additional Files

Published

2015-09-17

How to Cite

Yao, J., L. Cong, B. Zhu, and T. Wang. “Effect of Dietary Approaches to Stop Hypertension Diet Plan on Pregnancy Outcome Patients With Gestational Diabetes Mellitus”. Bangladesh Journal of Pharmacology, vol. 10, no. 4, Sept. 2015, pp. 732-8, doi:10.3329/bjp.v10i4.23813.

Issue

Vol. 10 No. 4 (2015)

Section

Clinical Trial

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).